Pharma hopes to avoid 'witch hunts' in financial disclosure

The association’s draft 17th Code of Conduct, submitted to the ACCC today for authorisation, includes several new disclosure requirements but will not require companies to disclose individual payments to doctors.

Companies will have to disclose aggregate payments to healthcare professionals for advisory positions, consultancies, speaking engagements, sponsorships for practitioners to attend educational events, and sponsorship of individual consumer organisations.

The draft code also includes a ban on marketing paraphernalia carrying the brand name